VistaGen Therapeutics’s Earnings: A Preview



VistaGen Therapeutics (NASDAQ:VTGN) is set to give its latest quarterly earnings report on Tuesday, 2024-02-13. Here’s what investors need to know before the announcement.

Analysts estimate that VistaGen Therapeutics will report an earnings per share (EPS) of $-0.30.

VistaGen Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, …

Full story available on


Leave a Reply

Your email address will not be published. Required fields are marked *